Amerise Biosciences
AMERISE · Financials > Finance - Investment Listing date: Feb. 23, 2007

Stock Price vs Company Growth
1d
2.2%
1w
2.2%
1m
2.2%
3m
23.7%
6m
0.0%
1y
40.3%
5y
1.7%
10y
18.7%
all
6.7%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec16Sep18Jun20Dec21Jun23Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

0.87 2.2%
0.83
1.16
Company Overview

Sales
0.04 Cr
Growth: -25.6%
Profit after Tax
-0.08 Cr
Growth: -36.6%
Micro Cap
5.75 Cr
P/S: 159.7x
Industry P/S: 8.6x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 0.04
Growth -25.6%
EBITDA N/A
P/S 159.7x
Dividend 0.0%
P/E -43.5x
Book Value ₹ 0.8
PEG Ratio 1.7x
ROE -1.5%
P/B 1.1x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Dec22Mar23Dec23Sep24
Promoters
Created with Highcharts 8.2.2Dec22Mar23Dec23Sep24
Others
Created with Highcharts 8.2.2Dec22Mar23Dec23Sep24
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in commodity trading and in financial year (FY) 2007 it entered into the trading of castor seeds.
Followers (1)